BMS-599626 (CAS 714971-09-2) is a research-grade compound supplied by TCI, known as a selective kinase inhibitor used in laboratory studies of HER-related cell signaling pathways. It is commonly applied in oncology research, including in vitro and in vivo assays investigating tumor growth and drug resistance mechanisms. The product is available in 10 mg and 50 mg packaging for pharmaceutical and biomedical research purposes.
TCI brochures (PDF)
- Antitumor Molecular-Targeted Agents 2026-09-17 · p. 1
- Receptor Tyrosine Kinase (RTK) Inhibitors 2026-04-06 · p. 1
- Cancer Research Reagents 2025-04-01 · p. 2
- Antimicrobials and Antitumor Agents for Research and Experimental Use 2025-04-24 · p. 17
- Pharmaceutical Ingredients for Research and Experimental Use 2026-03-09 · p. 18
- Reagents for Biological Research 2025-03-11 · p. 40
—
| Brand | — |
|---|---|
| CAS number | — |
| Molecular formula | — |
| Purity | — |
| Category | — |
| Pack sizes | — |
| Physical form | — |
| Storage | — |
—
—
Product Categories
- Biochemicals and ReagentsPharmaceutical Research Reagents (for Experimental Use)Antitumor Research Reagents (for Experimental Use)
- Cell BiologyCancer ResearchAntitumor Agents for Research
- Cell BiologyCell Signaling and NeuroscienceKinase/Phosphatase Biology
- Pharmaceutical Development and Drug Discovery ResearchPharmaceutical Research Reagents (for Experimental Use)Antitumor Research Reagents (for Experimental Use)







